As filed with the Securities and Exchange Commission on March 5, 2010
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
IRONWOOD PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
04-3404176 |
(State or other jurisdiction of |
|
(IRS Employer |
320 Bent Street Cambridge, Massachusetts |
|
02141 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
2010 Employee, Director And Consultant Equity Incentive Plan
(Full titles of the plans)
Peter
M. Hecht
Chief Executive Officer
320 Bent Street
Cambridge, Massachusetts 02141
(Name and address of agent for service)
(617) 621-7722
(Telephone number, including area code, of agent for service)
Please send copies of all communications to:
Paul M. Kinsella
Ropes & Gray LLP
One International Place
Boston, MA 02110
617-951-7000 (phone)
617-951-7050 (facsimile)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer o |
|
Accelerated filer o |
Non-accelerated
filer x |
|
Smaller reporting company o |
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|||
Title of
Each Class of |
|
Amount
to be |
|
Proposed
Maximum |
|
Proposed
Maximum |
|
Amount of |
|||
Class A Common Stock, $0.001 par value per share |
|
6,000,000 shares |
|
$ |
12.93 |
|
$ |
77,580,000 |
|
$ |
5,531.45 |
(1) Represents Class A Common Stock issuable upon exercise of options that have not yet been granted as of the date of this Registration Statement under the 2010 Employee, Director and Consultant Equity Incentive Plan. Pursuant to Rule 416(a) under the Securities Act of 1933, this Registration Statement also covers such additional shares of Class A Common Stock as may issued to prevent dilution from stock splits, stock dividends and similar transactions.
(2) Offering prices of options that have not yet been granted as of the date of this Registration Statement are computed in accordance with Rule 457(h) based on the average high and low prices of the Class A Common Stock as reported by the Nasdaq Global Market on March 1, 2010 to be $13.30 and $12.56, respectively.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
We incorporate by reference herein the following documents filed by Ironwood Pharmaceuticals, Inc. (the Registrant) with the Securities and Exchange Commission (the SEC):
All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated herein by reference from the date of filing of such documents. Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is incorporated or is deemed to be incorporated by reference herein modifies or supersedes such earlier statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
The registrants certificate of incorporation contains provisions that eliminate, to the maximum extent permitted by the General Corporation Law of the State of Delaware, the personal liability of directors and officers for monetary damages for breach of their fiduciary duties as a director or officer.
Section 145 of the General Corporation Law of the State of Delaware provides that a corporation may indemnify any person made a party to an action by reason of the fact that he or she was a director, executive officer, employee or agent of the corporation or is or was serving at the request of the corporation against expenses (including attorneys fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of an action by or in right of the corporation, no indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation. The Registrants certificate of incorporation and bylaws provide
that it shall indemnify its directors and executive officers and may indemnify its employees and other agents to the fullest extent permitted by the General Corporation Law of the State of Delaware.
The Registrant has entered into indemnification agreements with its directors and certain of its officers, in addition to the indemnification provided for in its certificate of incorporation and bylaws, and intends to enter into indemnification agreements with any new directors and executive officers in the future. The Registrant has purchased and intends to maintain insurance on behalf of any person who is or was a director or officer against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.
Reference is made to the form of underwriting agreement filed as Exhibit 1.1 to the Registrants registration statement on Form S-1 (File No. 333-163275), as amended, which provides for indemnification by the underwriters of the Registrant and its executive officers and directors, and by the Registrant of the underwriters, for certain liabilities, including liabilities arising under the Securities Act.
Item 7. Exemption From Registration Claimed.
Not applicable.
Item 8. Exhibits.
Exhibit
4.1 2010 Employee, Director and Consultant Equity Incentive Plan (previously filed as Exhibit 10.4 to the registration statement on Form S-1 (File No. 333-163275) and incorporated herein by reference).
4.2 Eleventh Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.2 to the registration statement on Form S-1 (File No. 333-163275) and incorporated herein by reference).
4.3 Fifth Amended and Restated Bylaws (previously filed as Exhibit 3.4 to the registration statement on Form S-1 (File No. 333-163275) and incorporated herein by reference).
5.1 Opinion of Ropes & Gray LLP.
23.1 Consent of Ernst & Young, LLP.
23.2 Consent of Ropes & Gray LLP (included in the opinion filed as Exhibit 5.1).
24.1 Powers of Attorney (included on the signature page in Part II).
Item 9. Undertakings.
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above shall not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on this 5th day of March, 2010.
|
IRONWOOD PHARMACEUTICALS, INC. |
|
|
|
|
|
By: |
/s/ PETER M. HECHT |
|
Name: |
Peter M. Hecht |
|
Title: |
Chief Executive Officer |
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Peter M. Hecht and Michael J. Higgins, and each of them acting individually, his or her true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 to be filed by Ironwood Pharmaceuticals, Inc., and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue hereof.
* * * *
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ PETER M. HECHT |
|
Chief Executive Officer and Director |
|
March 5, 2010 |
Peter M. Hecht |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
|
|
|
|
|
/s/ MICHAEL J. HIGGINS |
|
Chief Operating Officer & Chief Financial Officer |
|
March 5, 2010 |
Michael J. Higgins |
|
(Principal Financial Officer & |
|
|
|
|
Principal Accounting Officer) |
|
|
|
|
|
|
|
/s/ JOSEPH C. COOK, JR. |
|
Chairman of the Board |
|
March 5, 2010 |
Joseph C. Cook, Jr. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ GEORGE CONRADES |
|
Director |
|
March 5, 2010 |
George Conrades |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ DAVID EBERSMAN |
|
Director |
|
March 5, 2010 |
David Ebersman |
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ MARSHA FANUCCI |
|
Director |
|
March 5, 2010 |
Marsha Fanucci |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ TERRANCE G. MCGUIRE |
|
|
|
March 5, 2010 |
Terrance G. McGuire |
|
Director |
|
|
|
|
|
|
|
|
|
|
|
|
/s/ GINA BORNINO MILLER |
|
Director |
|
March 5, 2010 |
Gina Bornino Miller |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ BRYAN E. ROBERTS |
|
Director |
|
March 5, 2010 |
Bryan E. Roberts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ DAVID E. SHAW |
|
Director |
|
March 5, 2010 |
David E. Shaw |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ CHRISTOPHER T. WALSH |
|
Director |
|
March 5, 2010 |
Christopher T. Walsh |
|
|
|
|
EXHIBIT INDEX
4.1 |
|
2010 Employee, Director and Consultant Equity Incentive Plan (previously filed as Exhibit 10.4 to the registration statement on Form S-1 (File No. 333-163275) and incorporated herein by reference). |
|
|
|
4.2 |
|
Eleventh Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.2 to the registration statement on Form S-1 (File No. 333-163275) and incorporated herein by reference). |
|
|
|
4.3 |
|
Fifth Amended and Restated Bylaws (previously filed as Exhibit 3.4 to the registration statement on Form S-1 (File No. 333-163275) and incorporated herein by reference). |
|
|
|
5.1 |
|
Opinion of Ropes & Gray LLP. |
|
|
|
23.1 |
|
Consent of Ernst & Young, LLP. |
|
|
|
23.2 |
|
Consent of Ropes & Gray LLP (included in the opinion filed as Exhibit 5.1). |
|
|
|
24.1 |
|
Powers of Attorney (included on the signature page in Part II). |